gliclazide has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y; Lin, G; Ma, J; Miu, KK; Tang, C; Wang, Z; Yao, S; Ye, Y | 1 |
1 other study(ies) available for gliclazide and Chemical and Drug Induced Liver Injury, Chronic
| Article | Year |
|---|---|
Nrf2-mediated liver protection by 18β-glycyrrhetinic acid against pyrrolizidine alkaloid-induced toxicity through PI3K/Akt/GSK3β pathway.
Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury, Chronic; Endothelial Cells; Glycogen Synthase Kinase 3 beta; Glycyrrhetinic Acid; Liver; Liver Diseases; NF-E2-Related Factor 2; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyrrolizidine Alkaloids; Rats | 2022 |